Breaking News Instant updates and real-time market news.

AGR

Avangrid

$49.35

0.43 (0.88%)

, UNH

UnitedHealth

$273.75

-2.93 (-1.06%)

12:45
11/12/18
11/12
12:45
11/12/18
12:45

Avangrid names Peter Church chief HR officer

Avangrid (AGR) announced the appointment of Peter Church as Chief Human Resources Officer. In this role, Church will oversee Human Resources, Information Technology and General Services. Reporting to Avangrid CEO James Torgerson, Church will be responsible for developing and executing human resource strategies in support of the overall company business plan and strategic direction of the organization. Church comes to Avangrid from UnitedHealthcare (UNH), where he was Chief Talent Officer responsible for creating, leading and driving talent strategies, ensuring the ongoing and successful attraction, development and engagement of a world class workforce.

AGR

Avangrid

$49.35

0.43 (0.88%)

UNH

UnitedHealth

$273.75

-2.93 (-1.06%)

  • 12

    Nov

  • 12

    Nov

AGR Avangrid
$49.35

0.43 (0.88%)

10/29/18
10/29/18
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Electronic Arts (EA) downgraded to Sector Weight from Overweight at KeyBanc with analyst Evan Wingren saying he expects negative estimate revisions, and has diminished confidence in the pipeline, which is likely to continue to limit valuation expansion in the near-term. 2. Colgate-Palmolive (CL) downgraded to Underweight from Neutral at JPMorgan with analyst Andrea Teixeira saying she sees the company's "weak growth" continuing amid intense competition and cost challenges. 3. Palo Alto Networks (PANW) downgraded to Hold from Buy at Summit Insights. 4. Western Digital (WDC) downgraded to Hold from Buy at Loop Capital with analyst Ananda Baruah saying his work on the company's Q3 results has led to a conclusion that NAND memory average selling price declines could "exacerbate entering January" and believes that consensus view on the company's FY19 EPS remains too high. 5. Avangrid (AGR) downgraded to Neutral from Buy at Goldman Sachs with analyst Michael Lapides saying his revised earnings estimates now imply "significant downside risk" to company guidance and consensus numbers, especially for 2020. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/29/18
GSCO
10/29/18
DOWNGRADE
Target $50
GSCO
Neutral
Goldman downgraded Avangrid to Neutral on 'significant' guidance risk
Goldman Sachs analyst Michael Lapides downgraded Avangrid to Neutral from Buy and lowered his price target for the shares to $50 from $56. The analyst says his revised earnings estimates now imply "significant downside risk" to company guidance and consensus numbers, especially for 2020. Lapides reduces his 2018-2020 earnings estimates for Avangrid to account for revised rate case assumptions for the New York utilities given the company's intent to file for a rate case in mid-2019, the delayed timing of capital spend for major projects in New York, and "weak" Q3 earnings results.
10/28/18
GSCO
10/28/18
DOWNGRADE
GSCO
Neutral
Avangrid downgraded to Neutral from Buy at Goldman Sachs
08/13/18
WOLF
08/13/18
DOWNGRADE
WOLF
Underperform
Avangrid downgraded to Underperform from Peer Perform at Wolfe Research
Wolfe Research downgraded Avangrid to Underperform saying the company's large scale transmission and offshore wind projects will require significant capital investment and take years to complete.
UNH UnitedHealth
$273.75

-2.93 (-1.06%)

10/31/18
MZHO
10/31/18
NO CHANGE
Target $94
MZHO
Buy
Mizuho says concerns over UnitedHealth program impact on Gilead seem unwarranted
Mizuho analyst Salim Syed blames UnitedHealth's (UNH) introduction of a new a program, called "My ScriptRewards," that will try to convince plan participants to take a cheaper HIV regimen in return for $500 in debit cards for the weakness in shares of Gilead (GILD). However, the analyst views the worries as unwarranted, noting that Cimduo is the "common thread" between all of the regimens that UnitedHealth's program calls out and it is an inferior drug to Gilead's Biktarvy. Biktarvy is the backbone of the number one recommended regimen according to HHS treatment guidelines, noted Syed, who keeps a Buy rating and $94 price target on Gilead shares.
10/31/18
EVER
10/31/18
NO CHANGE
EVER
Outperform
Gilead sales not at risk from UnitedHealth promotions, says Evercore ISI
Evercore ISI analyst Umer Raffat attributes the pullback today in shares of Gilead Sciences (GILD) to concerns over the company's HIV franchise given UnitedHealth's (UNH) promotions of cheaper alternatives. UnitedHealth (UNH) is offering a rewards plan to patients starting with HIV medications to help promote the use of lower priced drugs, Jefferies analyst Michael Yee pointed out earlier today in a research note. Raffat, however, does not see risk to Gilead's sales from the promotions. UnitedHealth's is proposing a switch to two separate tablets, which is not in the HIV guidelines today, says the analyst. He keeps an Outperform rating on Gilead shares, which are down 6% to $68.00 in afternoon trading.
10/30/18
ARGS
10/30/18
DOWNGRADE
ARGS
Hold
LabCorp downgraded to Hold from Buy at Argus
Argus analyst Jasper Hellweg downgraded LabCorp (LH) to Hold from Buy after its Q3 earnings miss and a cut in FY18 guidance. The analyst notes that the company is faced with pressure from "lower lab testing payment rates mandated by the Protecting Access to Medicaid Act of 2014" along with business disruptions and the impact of acquisitions which resulted in lowers margins for the quarter. Hellweg further cites LabCorp's loss of "status as the exclusive national provider of laboratory services to UnitedHealthcare (UNH)" to rival Quest Diagnostics (DGX). In spite of these short-term challenges, the analyst also maintains a positive outlook for LabCorp on a long-term basis, adding that he would "consider an upgrade if the stock stabilized at the support level of $147 per share."
10/18/18
BMOC
10/18/18
NO CHANGE
Target $310
BMOC
Outperform
UnitedHealth price target raised to $310 from $300 at BMO Capital
BMO Capital analyst Matt Borsch raised his price target on UnitedHealth to $310 and kept his Outperform rating, saying the company's "very solid" Q3 results represent a turn in focus toward 2019. The analyst states that in addition to "many areas of strong execution", the key takeaway for the quarter was "relief on medical cost trend", which he sees as pivotal to the company achieving a near-30% earnings growth in FY18.

TODAY'S FREE FLY STORIES

14:05
12/13/18
12/13
14:05
12/13/18
14:05
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

14:01
12/13/18
12/13
14:01
12/13/18
14:01
General news
Treasury Budget data reported »

November Treasury Budget…

DFFN

Diffusion Pharmaceuticals

$0.23

0.0176 (8.32%)

14:01
12/13/18
12/13
14:01
12/13/18
14:01
Hot Stocks
Diffusion Pharmaceuticals announces 1-for-15 reverse stock split »

Diffusion Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QSR

Restaurant Brands

$54.38

0.35 (0.65%)

14:00
12/13/18
12/13
14:00
12/13/18
14:00
Options
Notable call activity in Restaurant Brands as bullish position is adjusted »

Notable call activity in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LVS

Las Vegas Sands

$55.27

-0.19 (-0.34%)

, WYNN

Wynn Resorts

$108.68

-0.79 (-0.72%)

13:59
12/13/18
12/13
13:59
12/13/18
13:59
Periodicals
Chanos shorting Wynn Resorts, Las Vegas Sands amid trade war, CNBC reports »

Short-seller Jim Chanos…

LVS

Las Vegas Sands

$55.27

-0.19 (-0.34%)

WYNN

Wynn Resorts

$108.68

-0.79 (-0.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBUX

Starbucks

$66.80

0.7 (1.06%)

13:56
12/13/18
12/13
13:56
12/13/18
13:56
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks sees growing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

SBUX

Starbucks

$66.81

0.71 (1.07%)

13:56
12/13/18
12/13
13:56
12/13/18
13:56
Hot Stocks
Breaking Hot Stocks news story on Starbucks »

Starbucks sees U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

13:55
12/13/18
12/13
13:55
12/13/18
13:55
General news
U.S. equities remain mixed after rotating lower »

U.S. equities remain…

CSTM

Constellium

$8.39

-0.02 (-0.24%)

13:51
12/13/18
12/13
13:51
12/13/18
13:51
Hot Stocks
Constellium trading higher by 1.67% during 2018 Analyst Day presentation »

Constellium management is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 17

    Dec

  • 18

    Dec

SBUX

Starbucks

$66.67

0.57 (0.86%)

13:45
12/13/18
12/13
13:45
12/13/18
13:45
Hot Stocks
Starbucks CEO says customer behaviors shifting rapidly, company must adapt »

Starbucks CEO Kevin…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

ADBE

Adobe

$245.82

0.38 (0.15%)

, COST

Costco

$225.99

-1.83 (-0.80%)

13:42
12/13/18
12/13
13:42
12/13/18
13:42
Earnings
Notable companies reporting after market close »

Notable companies…

ADBE

Adobe

$245.82

0.38 (0.15%)

COST

Costco

$225.99

-1.83 (-0.80%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 13

    Dec

SPY

SPDR S&P 500 ETF Trust

$264.81

-0.72 (-0.27%)

13:40
12/13/18
12/13
13:40
12/13/18
13:40
Options
Four-day hedge opened in SPYders »

Four-day hedge opened in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WYNN

Wynn Resorts

$109.16

-0.31 (-0.28%)

, LVS

Las Vegas Sands

$55.16

-0.3 (-0.54%)

13:36
12/13/18
12/13
13:36
12/13/18
13:36
Periodicals
Breaking Periodicals news story on Wynn Resorts, Las Vegas Sands »

Chanos shorting Wynn…

WYNN

Wynn Resorts

$109.16

-0.31 (-0.28%)

LVS

Las Vegas Sands

$55.16

-0.3 (-0.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JD

JD.com

$22.72

0.82 (3.74%)

13:30
12/13/18
12/13
13:30
12/13/18
13:30
Options
Call spreads in JD as shares gain 3.5% and a bullish position is adjusted »

Call spreads in JD as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HIL

Hill International

$2.98

-0.11 (-3.56%)

13:29
12/13/18
12/13
13:29
12/13/18
13:29
Hot Stocks
Hill International selected by the ERBD to provide railway supervision services »

Hill International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBAI

Lakeland Bancorp

$14.83

-0.27 (-1.79%)

13:27
12/13/18
12/13
13:27
12/13/18
13:27
Hot Stocks
Highlands Bancorp investors approve merger with Lakeland Bancorp »

Lakeland Bancorp and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NLSN

Nielsen

$25.70

-0.36 (-1.38%)

, BX

Blackstone

$30.22

-0.28 (-0.92%)

13:24
12/13/18
12/13
13:24
12/13/18
13:24
Periodicals
Nielsen to hold talks with potential buyers in January, CNBC says »

Nielsen (NLSN) intends to…

NLSN

Nielsen

$25.70

-0.36 (-1.38%)

BX

Blackstone

$30.22

-0.28 (-0.92%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TGT

Target

$66.44

-1.36 (-2.01%)

, WMT

Walmart

$92.78

-0.34 (-0.37%)

13:23
12/13/18
12/13
13:23
12/13/18
13:23
Hot Stocks
New York AG sues Target, Walmart over lead-contaminated toy sales »

New York Attorney General…

TGT

Target

$66.44

-1.36 (-2.01%)

WMT

Walmart

$92.78

-0.34 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

HIIQ

Health Insurance Innovations

$29.08

-0.985 (-3.28%)

13:21
12/13/18
12/13
13:21
12/13/18
13:21
Hot Stocks
Breaking Hot Stocks news story on Health Insurance Innovations »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

MET

MetLife

$39.30

-0.27 (-0.68%)

13:20
12/13/18
12/13
13:20
12/13/18
13:20
Options
Call buyer in MetLife lays out $57K for one-day trade »

Call buyer in MetLife…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Dec

HIIQ

Health Insurance Innovations

$29.08

-0.985 (-3.28%)

13:20
12/13/18
12/13
13:20
12/13/18
13:20
Hot Stocks
Breaking Hot Stocks news story on Health Insurance Innovations »

Health Insurance…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
12/13/18
12/13
13:17
12/13/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
12/13/18
12/13
13:16
12/13/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MELI

MercadoLibre

$338.18

-23.4 (-6.47%)

13:15
12/13/18
12/13
13:15
12/13/18
13:15
Options
MercadoLibre put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:15
12/13/18
12/13
13:15
12/13/18
13:15
General news
Treasury's $16 B 30-year reopening was ok, but nothing special »

Treasury's $16 B…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.